ArticleNeurology and therapy2026

Real-World, Long-Term Outcomes with Cladribine Tablets Versus Other Oral Treatments Among Patients with Multiple Sclerosis.

Ajay S Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.